These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25894593)

  • 1. Analysis of frequency of deep white matter metastasis on cerebral MRI.
    Seidel C; Hambsch P; Hering K; Bresch A; Rohde S; Kortmann RD; Gaudino C
    J Neurooncol; 2015 May; 123(1):135-9. PubMed ID: 25894593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter changes in breast cancer brain metastases patients who undergo radiosurgery alone compared to whole brain radiation therapy plus radiosurgery.
    Stokes TB; Niranjan A; Kano H; Choi PA; Kondziolka D; Dade Lunsford L; Monaco EA
    J Neurooncol; 2015 Feb; 121(3):583-90. PubMed ID: 25445836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy.
    Zhong X; Huang B; Feng J; Yang W; Liu H
    J Neurooncol; 2015 Oct; 125(1):177-81. PubMed ID: 26275366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White and Gray Matter Abnormalities After Cranial Radiation in Children and Mice.
    Nieman BJ; de Guzman AE; Gazdzinski LM; Lerch JP; Chakravarty MM; Pipitone J; Strother D; Fryer C; Bouffet E; Laughlin S; Laperriere N; Riggs L; Skocic J; Mabbott DJ
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):882-91. PubMed ID: 26530758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer.
    Monaco EA; Faraji AH; Berkowitz O; Parry PV; Hadelsberg U; Kano H; Niranjan A; Kondziolka D; Lunsford LD
    Cancer; 2013 Jan; 119(1):226-32. PubMed ID: 22707281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of metastases within the hypothalamic-pituitary area in patients with brain metastases.
    Janssen S; Mehta P; Bartscht T; Schmid SM; Fahlbusch FB; Rades D
    Radiat Oncol; 2019 Aug; 14(1):152. PubMed ID: 31455428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy.
    Sanghvi SM; Lischalk JW; Cai L; Collins S; Nair M; Collins B; Unger K
    Radiat Oncol; 2017 Feb; 12(1):43. PubMed ID: 28245881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of the apparent diffusion coefficient for the evaluation of the white matter to differentiate between glioblastoma and brain metastases.
    Miquelini LA; PĂ©rez Akly MS; Funes JA; Besada CH
    Radiologia; 2016; 58(3):207-13. PubMed ID: 26655126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: Local tumour control and survival.
    Oehlke O; Wucherpfennig D; Fels F; Frings L; Egger K; Weyerbrock A; Prokic V; Nieder C; Grosu AL
    Strahlenther Onkol; 2015 Jun; 191(6):461-9. PubMed ID: 25592907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated stereotactic radiotherapy with or without whole-brain radiotherapy for patients with newly diagnosed brain metastases from non-small cell lung cancer.
    Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L; Zhang XM
    J Neurosurg; 2012 Dec; 117 Suppl():49-56. PubMed ID: 23205789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer.
    Halasz LM; Uno H; Hughes M; D'Amico T; Dexter EU; Edge SB; Hayman JA; Niland JC; Otterson GA; Pisters KM; Theriault R; Weeks JC; Punglia RS
    Cancer; 2016 Jul; 122(13):2091-100. PubMed ID: 27088755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.
    Chang EL; Wefel JS; Hess KR; Allen PK; Lang FF; Kornguth DG; Arbuckle RB; Swint JM; Shiu AS; Maor MH; Meyers CA
    Lancet Oncol; 2009 Nov; 10(11):1037-44. PubMed ID: 19801201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukoencephalopathy After Stereotactic Radiosurgery for Brain Metastases.
    Trifiletti DM; Lee CC; Schlesinger D; Larner JM; Xu Z; Sheehan JP
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):870-8. PubMed ID: 26530756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
    Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
    J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aging in deep gray matter and white matter revealed by diffusional kurtosis imaging.
    Gong NJ; Wong CS; Chan CC; Leung LM; Chu YC
    Neurobiol Aging; 2014 Oct; 35(10):2203-16. PubMed ID: 24910392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study.
    Berk BA; Nagel S; Hering K; Paschke S; Hoffmann KT; Kortmann RD; Gaudino C; Seidel C
    J Neurooncol; 2016 Oct; 130(1):203-209. PubMed ID: 27535745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases.
    Jakubovic R; Sahgal A; Soliman H; Milwid R; Zhang L; Eilaghi A; Aviv RI
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):704-12. PubMed ID: 25023291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
    Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.